Literature DB >> 7650528

Medical and surgical treatment in neurocysticercosis a magnetic resonance study of 161 cases.

H R Martinez1, R Rangel-Guerra, J H Arredondo-Estrada, A Marfil, J Onofre.   

Abstract

In a prospective non-controlled study we have treated 161 consecutive cases of Active Neurocysticercosis (NCC) diagnosed by Magnetic Resonance (MR). Active NCC was classified in: (1) brain parenchymal cysts (85 cases); (2) ventricular cysts (24 cases); (3) subarachnoid cysts (46 cases); and (4) cysticercus racemose (6 cases). All patients had MR follow up 1 month after treatment. Twenty five patients had MR with gadopentetate dimeglumine (Gd) contrast enhancement. Cine MR was performed in one patient. Medical treatment with albendazole (ABZ) or Praziquantel (PZQ) was applied in 136 cases. Drug efficacy, assessed by disappearance of the lesion on MR, was 92.5% with ABZ and 60% with PZQ. Thirty patients were treated by surgery. Five patients of group I were treated surgically due either to refractory seizures or persistent abnormalities on MR. Ventricular cysts were removed in 20 cases; 4 cases with cysticercus racemose and one with subarachnoid spinal cyst were also treated by surgery. Two patients with 4th ventricle cysts received ABZ and ventricular shunt only. Two cases with intraventricular cysts (lateral ventricles) and two with racemose cysts were successfully treated with ABZ. The Gd infusion showed enhancement in cysts with adjacent inflammatory reaction or edema and in cases with meningeal inflammation. Cine MR was useful in the differential diagnosis with congenital arachnoid cyst. We conclude that (1) MR is sensitive in the diagnosis of active NCC and may be useful in evaluating degenerative changes in the parasite; (2) ABZ is highly effective in the treatment of parenchymal and subarachnoidal NCC; (3) Parenchymal lesions which remain with abnormal appearance on MR (Degenerative cysticerci or gliosis) and refractory seizures should be treated by surgery; (4) Cysticercus racemose without intracranial hypertension may be treated with ABZ; (5) Ventricular cysts are treated by surgical removal, however, ABZ and ventricular peritoneal shunt may also be an alternative approach.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7650528     DOI: 10.1016/0022-510x(94)00278-v

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  14 in total

1.  Improved detection of intraventricular cysticercal cysts with the use of three-dimensional constructive interference in steady state MR sequences.

Authors:  S S Govindappa; J P Narayanan; V M Krishnamoorthy; C H Shastry; A Balasubramaniam; S S Krishna
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

2.  High-dose praziquantel with cimetidine for refractory neurocysticercosis: a case report with clinical and MRI follow-up.

Authors:  T Yee; J A Barakos; R T Knight
Journal:  West J Med       Date:  1999-02

3.  MRI and in vivo proton MR spectroscopy in a racemose cysticercal cyst of the brain.

Authors:  P N Jayakumar; H S Chandrashekar; S G Srikanth; A S Guruprasad; B Indira Devi; S K Shankar
Journal:  Neuroradiology       Date:  2003-11-12       Impact factor: 2.804

4.  Isolated cysticercosis of the cauda equina.

Authors:  Maurizio Iacoangeli; Elisa Moriconi; Maurizio Gladi; Massimo Scerrati
Journal:  J Neurosci Rural Pract       Date:  2013-08

5.  Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients.

Authors:  O H Del Brutto
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-06       Impact factor: 10.154

Review 6.  Treatment of neurocysticercosis: current status and future research needs.

Authors:  T E Nash; G Singh; A C White; V Rajshekhar; J A Loeb; J V Proaño; O M Takayanagui; A E Gonzalez; J A Butman; C DeGiorgio; O H Del Brutto; A Delgado-Escueta; C A W Evans; R H Gilman; S M Martinez; M T Medina; E J Pretell; J Teale; H H Garcia
Journal:  Neurology       Date:  2006-10-10       Impact factor: 9.910

7.  Radiologic manifestations of intraventricular and subarachnoid racemose neurocysticercosis.

Authors:  J S Hauptman; C Hinrichs; C Mele; H J Lee
Journal:  Emerg Radiol       Date:  2005-04

Review 8.  Neurocysticercosis.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  1998-06       Impact factor: 2.401

Review 9.  Management of neurocysticercosis.

Authors:  Terrence Riley; A C White
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

Review 10.  Current consensus guidelines for treatment of neurocysticercosis.

Authors:  Hector H García; Carlton A W Evans; Theodore E Nash; Osvaldo M Takayanagui; A Clinton White; David Botero; Vedantam Rajshekhar; Victor C W Tsang; Peter M Schantz; James C Allan; Ana Flisser; Dolores Correa; Elsa Sarti; Jon S Friedland; S Manuel Martinez; Armando E Gonzalez; Robert H Gilman; Oscar H Del Brutto
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.